Gene · 3978
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Refined read-out: The hUHRF1 Tandem-Tudor domain prefers binding to histone H3 tails containing K4me1 in the context of H3K9me2/3. | Protein Sci | 2023 | 37593997 | PubTator, text mining | PubMed |
| How ligands regulate the binding of PARP1 with DNA: Deciphering the mechanism at the molecular level. | PLoS One | 2023 | 37582112 | PubTator, text mining | PubMed |
| Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing. | Nat Commun | 2023 | 37580318 | PubTator, text mining | PubMed |
Identification and validation of the diagnostic signature associated with immune microenvironment of acute kidney injury based on ferroptosis-related genes through integrated bioinformatics analysis and machine learning. | Front Cell Dev Biol | 2023 | 37576602 | PubTator, text mining | PubMed |
| Analysis of Copy Number Variation of DNA Repair/Damage Response Genes in Tumor Tissues. | Methods Mol Biol | 2023 | 37574486 | PubTator, text mining | PubMed |
| Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice. | Cancers (Basel) | 2023 | 37568746 | PubTator, text mining | PubMed |
| Structural and functional studies of PCNA from African swine fever virus. | J Virol | 2023 | 37534905 | PubTator, text mining | PubMed |
| Feature selection translates drug response predictors from cell lines to patients. | Front Genet | 2023 | 37519889 | PubTator, text mining | PubMed |
| Hepatitis Delta Virus-Host Protein Interactions: From Entry to Egress. | Viruses | 2023 | 37515216 | PubTator, text mining | PubMed |
| LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study. | Molecules | 2023 | 37513188 | PubTator, text mining | PubMed |
| Improvement of Supercapacitor Performance of In Situ Doped Laser-Induced Multilayer Graphene via NiO. | Nanomaterials (Basel) | 2023 | 37513092 | PubTator, text mining | PubMed |
| Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease. | Int J Mol Sci | 2023 | 37511066 | PubTator, text mining | PubMed |
| Therapeutic Targeting of DNA Replication Stress in Cancer. | Genes (Basel) | 2023 | 37510250 | PubTator, text mining | PubMed |
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
| Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia. | Sci Rep | 2023 | 37507442 | PubTator, text mining | PubMed |
| HDAC-an important target for improving tumor radiotherapy resistance. | Front Oncol | 2023 | 37503317 | PubTator, text mining | PubMed |
| FUS Unveiled in Mitochondrial DNA Repair and Targeted Ligase-1 Expression Rescues Repair-Defects in FUS-Linked Neurodegeneration. | Res Sq | 2023 | 37502965 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. | Res Sq | 2023 | 37502925 | PubTator, text mining | PubMed |
| Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity. | EMBO J | 2023 | 37492888 | PubTator, text mining | PubMed |
| Immune escape and resistance to immunotherapy in mismatch repair deficient tumors. | Front Immunol | 2023 | 37492581 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3978/papers?page=8